Copanlisib dihydrochloride
Copanlisib dihydrochloride - the dihydrochloride salt form of copanlisib, a phosphoinositide 3-kinase (pi3k) inhibitor with potential antineoplastic activity. Copanlisib inhibits the activation of the pi3k signaling pathway, which may result in inhibition of tumor cell growth and survival in susceptible tumor cell populations. Activation of the pi3k signaling pathway is frequently associated with tumorigenesis and dysregulated pi3k signaling may contribute to tumor resistance to a variety of antineoplastic agents. See copanlisib hydrochloride
Resources[edit source]
Latest articles - Copanlisib dihydrochloride
 | This medical article is a stub. You can help WikiMD by expanding it. |
Source: Data courtesy of the U.S. National Library of Medicine. Since the data might have changed, please query MeSH on Copanlisib dihydrochloride for any updates.
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD
